Direct Renin Inhibition
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Internal Medicine
Reference56 articles.
1. Angiotensin II AT2 receptor subtype
2. Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?
3. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials
4. Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials
5. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Silencing liver angiotensinogen synthesis as a novel approach to hypertension management: promises and challenges;European Heart Journal;2023-09-08
2. Pharmacogenomics Informs Cardiovascular Pharmacotherapy;Methods in Molecular Biology;2022
3. Effect of direct renin inhibition on vascular function after long-term treatment with aliskiren in hypertensive and diabetic patients;Journal of Hypertension;2020-07-28
4. Dual RAAS inhibition and cardiorenal disease: is enough really enough?;Internal and Emergency Medicine;2020-03-21
5. Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits;Internal and Emergency Medicine;2019-12-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3